For use in patients with hemophilia for short term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. It can also be used for excessive bleeding in menstruation, surgery, or trauma cases
Description
Tranexamic acid is a anti-fibrinolytic agent. Tranexamic acid inhibits fibrinolysis by blocking the binding of plasminogen and plasmin to fibrin, thus preventing dissolution of the haemostatic plug.
Primary dysmenorrhoea and pain associated with menorrhagia in women.
Description
Tranexamic acid is a anti-fibrinolytic agent. Tranexamic acid inhibits fibrinolysis by blocking the binding of plasminogen and plasmin to fibrin, thus preventing dissolution of the haemostatic plug.
Mefenamic Acid is a non-steroidal anti-inflammatory drug (NSAID). It inhibits cyclooxygenase-1 and -2 (COX-1 and -2), thus resulting in reduced rate of prostaglandin synthesis. It exhibits analgesic and anti-inflammatory and antipyretic properties. Inhibition of prostaglandin synthesis accounts for their analgesic and anti-inflammatory effects.
